Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival

Molecular Imaging and Biology

Volumn 8, Issue 3, 2006, Pages 163-170

  Gheysens, Olivier ^a   Lin, Shuan ^a   Cao, Feng ^a   Wang, Dongxu ^a   Chen, Ian Y ^a   Rodriguez Porcel, Martin ^a   Min, Jung J ^a   Gambhir, Sanjiv S ^a,b   Wu, Joseph C ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell transplant; Cyclosporine; Molecular imaging; Mycophenolate; Tacrolimus

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; FIREFLY LUCIFERASE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM CHLORIDE; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DONOR; DRUG EFFICACY; EMBRYO; ENZYME ACTIVITY; GRAFT REJECTION; MALE; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYCLOSPORINE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; LUMINESCENCE; MYCOPHENOLIC ACID; MYOBLASTS; RATS; RATS, SPRAGUE-DAWLEY; TACROLIMUS; TRANSFECTION;

EID: 33746879190     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-006-0038-3     Document Type: Article

References (36)

1. Goldman S (2005) Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23:862-871
2. Chien KR, Karsenty G (2005) Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120:533-544
3. Bonner-Weir S, Weir GC (2005) New sources of pancreatic beta-cells. Nat Biotechnol 23:857-861
4. Hofmann M, Wollert KC, Meyer GP, et al. (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202
5. Bulte JW, Douglas T, Witwer B, et al. (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141-1147
6. Kraitchman DL, Heldman AW, Atalar E, et al. (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290-2293
7. Bulte JW, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499
8. Wu JC, Chen IY, Sundaresan G, Min JJ, De A, Qiao JH, Fishbein MC, Gambhir SS (2003) Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108:1302-1305
9. Weissleder R, Moore A, Mahmood U, et al. (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351-355
10. Wu JC, Tseng JR, Gambhir SS (2004) Molecular imaging of cardiovascular gene products. J Nucl Cardiol 11:491-505
11. Skuk D, Tremblay JP (2003) Cell therapies for inherited myopathies. Curr Opin Rheumatol 15:723-729
12. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD (1996) Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98:2512-2523
13. Muller-Ehmsen J, Peterson KL, Kedes L, et al. (2002) Rebuilding a damaged heart: Long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105:1720-1726
14. Skuk D, Caron N, Goulet M, Roy B, Espinosa F, Tremblay JP (2002) Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant 11:671-681
15. Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367-381
16. Tarnowski BI, Spinale FG, Nicholson JH (1991) DAPI as a useful stain for nuclear quantitation. Biotech Histochem 66:297-302
17. Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA (1996) Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation 94:II332-II336
18. Wang C, Sun J, Sheil AG, McCaughan GW, Bishop GA (2001) A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 72:44-51
19. Skuk D, Goulet M, Roy B, Tremblay JP (2002) Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: Toward defining strategies applicable to humans. Exp Neurol 175:112-126
20. Camirand G, Caron NJ, Asselin I, Tremblay JP (2001) Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. Transplantation 72:38-44
21. Smythe GM, Hodgetts SI, Grounds MD (2000) Immunobiology and the future of myoblast transfer therapy. Mol Ther 1:304-313
22. Gussoni E, Soneoka Y, Strickland CD, et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394
23. Mendell JR, Kissel JT, Amato AA, et al. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 333:832-838
24. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD (2000) Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9:489-502
25. Rando TA, Pavlath GK, Blau HM (1995) The fate of myoblasts following transplantation into mature muscle. Exp Cell Res 220:383-389
26. Hardinger KL, Koch MJ, Brennan DC (2004) Current and future immunosuppressive strategies in renal transplantation. Pharmacotherapy 24:1159-1176
27. Huard J, Roy R, Guerette B, Verreault S, Tremblay G, Tremblay JP (1994) Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 17:224-234
28. Sammels LM, Bosio E, Fragall CT, Grounds MD, van Rooijen N, Beilharz MW (2004) Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 77:1790-1797
29. Muller-Ehmsen J, Whittaker P, Kloner RA, et al. (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34:107-116
30. Reinecke H, Murry CE (2002) Taking the death toll after cardiomyocyte grafting: A reminder of the importance of quantitative biology. J Mol Cell Cardiol 34:251-253
31. Reinecke H, Zhang M, Bartosek T, Murry CE (1999) Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 100:193-202
32. Cao YA, Bachmann MH, Beilhack A, et al. (2005) Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80:134-139
33. Wu JC, Sundaresan G, Iyer M, Gambhir SS (2001) Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 4:297-306
34. Swift SM, Clayton HA, London NJ, James RF (1998) The potential contribution of rejection to survival of transplanted human islets. Cell Transplant 7:599-606
35. Ostrowska A, Karrer FM, Bilir BM (1999) Histological identification of purified and cryopreserved allogeneic hepatocytes following transplantation in a murine model without host immunosuppression. Transpl Int 12:188-194
36. Barker RA, Dunnett SB, Faissner A, Fawcett JW (1996) The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 141:79-93